Neoclav 250 mg+62.5 mg (Tablet)
Medicine Details
Category | Details |
---|---|
Generic | Cefuroxime axetil clavulanic acid |
Company | Jenphar bangladesh ltd |
Also available as |
Title and Categories
- Neoclav 250 mg Tablet
- Medicine
- Cephalosporin Antibiotic
- Beta-lactamase Inhibitor
Color Options
- White
Dosage Form
Tablet
Packaging Options
- Blister Pack
- Bottle
Pack Size Options
- 10 Tablets
- 20 Tablets
- 30 Tablets
Age Group
- Adults
- Adolescents (13 years and older)
- Pediatric Patients (3 months to 12 years)
Indications
- Pharyngitis/Tonsillitis caused by Streptococcus pyogenes
- Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis
- Lower respiratory tract infections including pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella spp., Staphylococcus aureus, E. coli
- Uncomplicated skin and skin-structure infections caused by Staphylococcus aureus or Streptococcus pyogenes
- Uncomplicated urinary tract infections caused by E.coli or Klebsiella pneumoniae
- Bone and Joint Infections caused by Staphylococcus aureus
- Uncomplicated Gonorrhoea caused by Neisseria gonorrhoeae
- Early Lyme Disease caused by Borrelia burgdorferi
- Septicemia caused by Staphylococcus aureus, Streptococcus pneumoniae, E.coli, Haemophilus influenzae & Klebsiella spp.
- Meningitis caused by Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis & Staphylococcus aureus
Pharmacology
Bactericidal second generation cephalosporin antibiotic active against a wide range of Gram-positive and Gram-negative susceptible organisms
Mechanism of Action
Interferes with bacterial cell wall synthesis by interfering with the transpeptidation process
Dosage and Administration
- Adolescents and Adults (13 years and older):
- Pharyngitis/tonsillitis: 250 mg b.i.d. for 5-10 days
- Acute bacterial maxillary sinusitis: 250 mg b.i.d. for 10 days
- Acute bacterial exacerbation of chronic bronchitis: 250-500 mg b.i.d. for 10 days
- Secondary bacterial infections of acute bronchitis: 250-500 mg b.i.d. for 5-10 days
- Uncomplicated skin and skin structure infections: 250-500 mg b.i.d. for 10 days
- Uncomplicated urinary tract infections: 250 mg b.i.d. for 7-10 days
- Uncomplicated Gonorrhoea: 1000 mg b.i.d. single dose
- Community acquired pneumonia: 250-500 mg b.i.d. for 5-10 days
- MDR Typhoid Fever: 500 mg b.i.d. for 10-14 days
- Early Lyme disease: 500 mg b.i.d. for 20 days
- Pediatric Patients (3 months to 12 years):
- Pharyngitis/Tonsillitis: 20 mg/kg/day b.i.d for 5-10 days
- Acute otitis media: 30 mg/kg/day b.i.d for 10 days
- Acute bacterial maxillary sinusitis: 30 mg/kg/day b.i.d for 10 days
- Impetigo: 30 mg/kg/day b.i.d for 10 days
- Administration: May be taken without regard to food
Interaction
Concomitant administration of probenecid with Cefuroxime-Clavulanic Acid increases the serum concentration level. Drug that reduces gastric acidity may result in lower bioavailability.
Contraindications
- Known allergy to cephalosporin
- Pseudomembranous Colitis
Side Effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal discomfort or pain
- Prolonged administration may result in overgrowth of nonsusceptible microorganisms
- Rarely (<0.2%): renal dysfunction, anaphylaxis, angioedema, pruritis, rash, serum sickness like urticaria
Pregnancy and Lactation
Avoid in first trimester if possible. Can be used in later pregnancy and excreted into breast milk in small quantities
Precautions and Warnings
Given with care to patients receiving concurrent treatment with potent diuretics & patients with history of colitis
Therapeutic Class
Second generation Cephalosporins
Storage Conditions
Store in a cool, dry place (below 30°C), away from light and moisture. Keep out of the reach of children.
Related Brands
- Cefaclav 125 mg+31.25 mg (Tablet) - incepta-pharmaceuticals-ltd
- Cefaclav 250 mg+62.5 mg (Tablet) - incepta-pharmaceuticals-ltd
- Cefaclav 500 mg+125 mg (Tablet) - incepta-pharmaceuticals-ltd
- Cefuxet Plus 500 mg+125 mg (Tablet) - chemist-laboratories-ltd
- Clavusef 125 mg+31.25 mg (Tablet) - opsonin-pharma-ltd